Development of a Molecular Diagnostic Tool for Endometrial Cancer.

Status Recruiting

Clinical Trial Summary

WomEC is an in vitro diagnostic test for Endometrial Cancer (EC) based on the detection of the expression level of a combination of 5 proteins in the soluble fraction of a pipelle biopsy specimen. The aim of the study consists in validating WomEC's ELISA test, creating and freezing an algorithm to rule out EC in post-menopausal women with abnormal uterine bleeding (AUB).

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06192017
Study type	Observational [Patient Registry]
Source	MiMARK Diagnostics, S.L.
Contact	Antonio Gil-Moreno, MD, PhD
Phone	934893066
Email	antonio.gil@vallhebron.cat
Status	Recruiting
Phase
Start date	October 18, 2023
Completion date	October 17, 2024

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05036681` - A Phase II Study of Futibatinib and Pembrolizumab in Metastatic Microsatellite Stable Endometrial Carcinoma	Phase 2
Completed	`NCT00377520` - A Trial for Patients With Advanced/Recurrent Endometrial Cancer	Phase 2
Recruiting	`NCT05902988` - A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer	Phase 1/Phase 2
Completed	`NCT03899441` - Multimedia Aid Gynecologic Counseling and Consent	N/A
Completed	`NCT02552121` - Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors	Phase 1/Phase 2
Completed	`NCT02001623` - Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors	Phase 1/Phase 2
Completed	`NCT02997553` - Fluorescence for Sentinel Lymph Node Identification in Cancer Surgery	Phase 3
Suspended	`NCT03095664` - Effect of a Lifestyle Intervention on Nutritional Status and Prognosis of Endometrial Cancer Survivors	N/A
Active, not recruiting	`NCT01466777` - Endometrial Cancer and Robotic-assisted Versus Traditional Laparoscopy	N/A
Completed	`NCT01068483` - Safety of BKM120 Monotherapy in Advanced Solid Tumor Patients	Phase 1
Recruiting	`NCT03896113` - Neoadjuvant Celecoxib in Newly Diagnosed Patients With Endometrial Carcinoma	Phase 2
Not yet recruiting	`NCT03570866` - PET/CT in the Management of Patients With Early Stage Endometrial Cancer
Completed	`NCT05246462` - The Effect of Logotherapy on Mental Health in Gynecological Cancer Patients	N/A
Withdrawn	`NCT04464967` - Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR Cancers	Phase 1/Phase 2
Recruiting	`NCT05651282` - Risk Evaluation and Screening to Tailor Prevention and Reduce the Incidence of Endometrial Cancer	Phase 4
Completed	`NCT06187558` - Suspension of the Pelvic and Abdominal Organs During Minimally Invasive Surgery
Completed	`NCT06312917` - Effect of Physical Activity Intervention on Overweight and Obese Patients With Endometrial Cancer	N/A
Active, not recruiting	`NCT03951415` - Durvalumab and Olaparib in Metastatic or Recurrent Endometrial Cancer	Phase 2
Recruiting	`NCT04212910` - Stratifying Endometrial Cancer Patients Using a PET/MRI Prognostic Model
Completed	`NCT02221076` - Probe-based and Needle-based Confocal Laser Endomicroscopy During Gynaecological Procedures.	N/A